Alector, Inc.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ALECTOR, INC. | ||
| Date: February 25, 2026 | By: | /s/ Arnon Rosenthal |
|---|---|---|
| Arnon Rosenthal, Ph.D. | ||
| Co-founder and Chief Executive Officer | ||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Arnon Rosenthal, Ph.D., Neil Berkley, and Grace Wong-Sarad as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and substitution, for him or her and in his or her name, place, and stead, in any and all capacities (including his capacity as a director and/or officer of Alector, Inc.) to sign any or all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they, he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents or any of them, or their, his, or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Arnon Rosenthal Arnon Rosenthal, Ph.D. | Co-founder, Chief Executive Officer, and Director(Principal Executive Officer) | February 25, 2026 |
| /s/ Neil Berkley Neil Berkley | Chief Financial Officer and Chief Business Officer(Principal Financial Officer) | February 25, 2026 |
| /s/ Grace Wong-Sarad Grace Wong-Sarad | Vice President, Accounting(Principal Accounting Officer) | February 25, 2026 |
| /s/ Lou J. Lavigne, Jr. Louis J. Lavigne, Jr. | Director | February 25, 2026 |
| /s/ Elizabeth Garofalo Elizabeth Garofalo, M.D. | Director | February 25, 2026 |
| /s/ Paula Hammond Paula Hammond, Ph.D. | Director | February 25, 2026 |
| /s/ Mark Altmeyer Mark Altmeyer | Director | February 25, 2026 |
| /s/ Richard Scheller Richard Scheller, Ph.D. | Director | February 25, 2026 |
| /s/ Kristine Yaffe Kristine Yaffe, M.D. | Director | February 25, 2026 |
|---|---|---|
| /s/ Errol De Souza Errol De Souza, Ph.D. | Director | February 25, 2026 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.